1-8 of 8
Robin A. Roberts
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Major Histocompatibility Class II (MHCII) and Germinal Center Associated Gene Expression Correlate with Overall Survival in Ritiximab and CHOP-Like Treated Diffuse Large B Cell Lymphoma (DLBCL) Patients Using Formalin Fixed Paraffin Embedded (FFPE) Tissues.

Lisa M. Rimsza, MD, Michael L. LeBlanc, PhD, Robin A. Roberts, BS, Joseph M. Unger, MS, Thomas P. Miller, MD, Constantine M. Sabalos, MS, Ralph R. Martel, PhD, Elias Campo, MD, Andreas Rosenwald, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD, Natalie Johnson, MD, Randy D. Gascoyne, MD
Journal: Blood
Blood (2007) 110 (11): 50.
https://doi.org/10.1182/blood.V110.11.50.50
Published: 2007
Journal Articles

Gene Expression Differences between Low and High Stage Diffuse Large B Cell Lymphoma (DLBCL).

Robin A. Roberts, BS, Lisa M. Rimsza, M.D., Louis Staudt, M.D.Ph.D., Andreas Rosenwald, M.D., Wing-Chung Chan, M.D., Sandeep Dave, M.D., Randy D. Gascoyne, M.D., Joseph M. Connors, M.D., Erlend B. Smeland, M.D.Ph.D., H.K. Muller-Hermelink, M.D., Elias Campo, M.D., Elaine S. Jaffe, M.D., Wyndham Wilson, M.D., Bruce K. Tan, M.D., Richard I. Fisher, M.D., Thomas M. Grogan, M.D., Thomas P. Miller, MD
Journal: Blood
Blood (2006) 108 (11): 809.
https://doi.org/10.1182/blood.V108.11.809.809
Published: 2006
Journal Articles

Loss of Major Histocompatibility Class II (MHCII) Gene Expression in Diffuse Large B Cell Lymphoma (DLBCL) Is Not Generally Due to Genetic Mutations in the Coding Regions of CIITA or RFX.

Robin A. Roberts, BS, Thomas P. Miller, M.D., Lisa M. Rimsza, MD
Journal: Blood
Blood (2006) 108 (11): 2039.
https://doi.org/10.1182/blood.V108.11.2039.2039
Published: 2006
Journal Articles

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

Clinical Trials & Observations
Robin A. Roberts, George Wright, Andreas R. Rosenwald, Marina A. Jaramillo, Thomas M. Grogan, Thomas P. Miller, Yvette Frutiger, Wing C. Chan, Randy D. Gascoyne, German Ott, H. Konrad Muller-Hermelink, Louis M. Staudt, Lisa M. Rimsza
Journal: Blood
Blood (2006) 108 (1): 311–318.
https://doi.org/10.1182/blood-2005-11-4742
Published: 2006
Journal Articles

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Lisa M. Rimsza, Robin A. Roberts, Elias Campo, Thomas M. Grogan, Silvia Bea, Itziar Salaverria, Andreas Zettl, Andreas Rosenwald, German Ott, H. Konrad Muller-Hermelink, Jan Delabie, Richard I. Fisher, Joseph M. Unger, Michael LeBlanc, Louis M. Staudt, Elaine S. Jaffe, Randy D. Gascoyne, Wing C. Chan, Dennis D. Weisenburger, Timothy Greiner, Rita M. Braziel, Thomas P. Miller
Journal: Blood
Blood (2006) 107 (3): 1101–1107.
https://doi.org/10.1182/blood-2005-04-1510
Published: 2006
Journal Articles

A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis

Clinical Trials & Observations
Margaret E. Tome, David B. F. Johnson, Lisa M. Rimsza, Robin A. Roberts, Thomas M. Grogan, Thomas P. Miller, Larry W. Oberley, Margaret M. Briehl
Journal: Blood
Blood (2005) 106 (10): 3594–3601.
https://doi.org/10.1182/blood-2005-02-0487
Published: 2005
Journal Articles

Gene Expression Profiling, Frozen and Paraffin Section Immunohistochemistry, and In Situ Hybridization for Determination of Monoclonality in Diffuse Large B-Cell Lymphoma.

Matthew W. Andres, DO, Robin A. Roberts, BS, Debbie J. Mustacich, PhD, Randy D. Gascoyne, MD, Deborah A. Fuchs, MD, Michael X. Wang, MD, Rita M. Braziel, MD, Wing C. Chan, MD, Thomas M. Grogan, MD, Lisa M. Rimsza, MD
Journal: Blood
Blood (2004) 104 (11): 4553.
https://doi.org/10.1182/blood.V104.11.4553.4553
Published: 2004
Journal Articles

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Clinical Trials & Observations
Lisa M. Rimsza, Robin A. Roberts, Thomas P. Miller, Joseph M. Unger, Michael LeBlanc, Rita M. Braziel, Dennis D. Weisenberger, Wing C. Chan, H. Konrad Muller-Hermelink, Elaine S. Jaffe, Randy D. Gascoyne, Elias Campo, Deborah A. Fuchs, Catherine M. Spier, Richard I. Fisher, Jan Delabie, Andreas Rosenwald, Louis M. Staudt, Thomas M. Grogan
Journal: Blood
Blood (2004) 103 (11): 4251–4258.
https://doi.org/10.1182/blood-2003-07-2365
Published: 2004